The global demand for sitagliptin phosphate, the active pharmaceutical ingredient (API) behind leading type 2 diabetes medications, has entered a new era. With key patents having expired across major markets, the landscape has shifted dramatically from a branded monopoly to a highly competitive generic marketplace. This transformation has unlocked a vast and diverse pool of international buyers seeking reliable, cost-effective API sources. For exporters, manufacturers, and procurement specialists, a well-researched sitagliptin phosphate global buyers list is no longer a luxury—it is an essential tool for market entry, expansion, and competitive intelligence. This comprehensive guide moves beyond a simple directory. It provides a strategic analysis of the global sitagliptin phosphate buyer…